omparing the effect of probiotic and fluconazole in treatment and recurrent of vaginal candidiasis: A three-blind randomised controlled trial

Phase 3

Recruiting

• Conditions: vaginal candidiasis.; Candidiasis of vulva and vagina; B37.3

• Registration Number: IRCT20110826007418N5
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

Married women aged 15-49 (lack of virginity)
Positive culture of discharge from the candidate's point of view
Be literate
Willingness to participate in the study and the possibility of visiting the clinic at the requested times
Having a contact phone
Living in the city of Tabriz

Exclusion Criteria

Pregnancy, lactation and menopause
Use of antibiotics and immunosuppressive drugs (corticosteroids, etc.) and use of vaginal drugs during the last two weeks
Currently taking oral contraceptives according to the participant
Having autoimmune diseases
Having chronic diseases such as diabetes, anemia, hypothyroidism, etc.
Having menstrual bleeding during the visit of the participant
Abnormal uterine bleeding
Non-candidal vaginitis
Recurrent vulvovaginitis (four or more cases during the year)
Symptoms of drug allergy
Consumption of any probiotic product (supplements, food, etc.)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Frequency of negative culture in two intervention groups. Timepoint: Day 40-35 after starting treatment and day 65-60 after starting treatment. Method of measurement: Cultivation in the laboratory.